CA2436208C - A novel virus (cryptovirus) within the rubulavirus genus and uses therefor - Google Patents

A novel virus (cryptovirus) within the rubulavirus genus and uses therefor Download PDF

Info

Publication number
CA2436208C
CA2436208C CA2436208A CA2436208A CA2436208C CA 2436208 C CA2436208 C CA 2436208C CA 2436208 A CA2436208 A CA 2436208A CA 2436208 A CA2436208 A CA 2436208A CA 2436208 C CA2436208 C CA 2436208C
Authority
CA
Canada
Prior art keywords
cryptovirus
seq
leu
antibody
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2436208A
Other languages
English (en)
French (fr)
Other versions
CA2436208A1 (en
Inventor
Steven J. Robbins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRYPTIC AFFLICTIONS LLC
Original Assignee
CRYPTIC AFFLICTIONS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRYPTIC AFFLICTIONS LLC filed Critical CRYPTIC AFFLICTIONS LLC
Publication of CA2436208A1 publication Critical patent/CA2436208A1/en
Application granted granted Critical
Publication of CA2436208C publication Critical patent/CA2436208C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
CA2436208A 2001-02-07 2002-02-07 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor Expired - Fee Related CA2436208C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26725301P 2001-02-07 2001-02-07
US60/267,253 2001-02-07
PCT/US2002/004117 WO2002077211A2 (en) 2001-02-07 2002-02-07 A virus (cryptovirus) within the rubulavirus genus and uses therefor

Publications (2)

Publication Number Publication Date
CA2436208A1 CA2436208A1 (en) 2002-10-03
CA2436208C true CA2436208C (en) 2014-04-15

Family

ID=23017976

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2436208A Expired - Fee Related CA2436208C (en) 2001-02-07 2002-02-07 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor

Country Status (6)

Country Link
EP (1) EP1373477B1 (https=)
JP (1) JP4324379B2 (https=)
AT (1) ATE517179T1 (https=)
AU (2) AU2002306472C1 (https=)
CA (1) CA2436208C (https=)
WO (1) WO2002077211A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
FR2938840B1 (fr) * 2008-11-21 2010-12-17 Centre Nat Rech Scient Proteines mutantes de la proteine f de piv-5 et de piv-2
FR2938841B1 (fr) 2008-11-21 2010-12-17 Centre Nat Rech Scient Proteines mutantes de la proteine f de piv-5 et de piv-2
WO2011150320A2 (en) * 2010-05-27 2011-12-01 University Of Georgia Research Foundation, Inc. Activators of innate immunity
CN113481185B (zh) * 2021-08-05 2022-12-02 云南师范大学 一种耐盐β-半乳糖苷酶GalNC2-13及其制备方法和应用
WO2025076466A2 (en) * 2023-10-06 2025-04-10 Cyanvac Llc Piv5-based vaccines with modified antigen: methods of making and using the same

Also Published As

Publication number Publication date
AU2002306472B2 (en) 2008-03-06
JP2005503766A (ja) 2005-02-10
WO2002077211A8 (en) 2002-11-21
JP4324379B2 (ja) 2009-09-02
ATE517179T1 (de) 2011-08-15
CA2436208A1 (en) 2002-10-03
WO2002077211A3 (en) 2003-10-16
AU2002306472C1 (en) 2008-10-30
AU2008202524A1 (en) 2008-06-26
EP1373477A2 (en) 2004-01-02
WO2002077211A2 (en) 2002-10-03
EP1373477B1 (en) 2011-07-20

Similar Documents

Publication Publication Date Title
KR100964413B1 (ko) 감응성 포유류에서 호흡계 질환을 유발하는 바이러스
Mahapatra et al. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex
Fraser et al. Measles virus and its biology
AU2008202524A1 (en) Neurovirulent virus (cryptovirus) within the rebulavirus genus and uses therefor
Blixenkrone-Møller et al. Role of CD46 in measles virus infection in CD46 transgenic mice
US10329584B2 (en) Modified Sendai virus vaccine and imaging vector
US20060053501A1 (en) Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
AU2002306472A1 (en) Neurovirulent Virus (Cryptovirus) Within the Rubulavirus Genus and Uses Therefor
Loughlin et al. The cell biology of acute childhood respiratory disease: therapeutic implications
US6899884B2 (en) Vaccine against mumps containing a jeryl-lynn virus strain
US20110200630A1 (en) Live attenuated virus vaccines for la crosse virus and other bunyaviridae
AKASU Outbreak of Aseptic Meningitis due to ECHO-9 in Northern Kyushu Island inthe Summer of 1997
Greene et al. Feline paramyxovirus infections
HK1070383A (en) Vaccine against mumps
HK1012421B (en) Vaccine against mumps containing a jeryl-lynn virus strain
Welter Development of a canine distemper virus model in ferrets for testing novel Morbillivirus vaccine strategies
Vivo Recombinant Measles Viruses with

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160208